APA (7th ed.) Citation

Goeun Choi, Huiyan Piao, N. Sanoj Rejinold, Seungjin Yu, Ki-yeok Kim, Geun-woo Jin, & Jin-Ho Choy. (2021). Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections. MDPI AG.

Chicago Style (17th ed.) Citation

Goeun Choi, Huiyan Piao, N. Sanoj Rejinold, Seungjin Yu, Ki-yeok Kim, Geun-woo Jin, and Jin-Ho Choy. Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation Towards SARS-CoV-2 Viral Infections. MDPI AG, 2021.

MLA (9th ed.) Citation

Goeun Choi, et al. Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation Towards SARS-CoV-2 Viral Infections. MDPI AG, 2021.